Systemic toxicity from repeated cutaneous contact with 2,4-pentanedione

Area of Science:

• Toxicology
• Dermatology
• Neuroscience

Background:

• 2,4-Pentanedione (2,4 PD) is an industrial chemical with known systemic toxicity via oral and inhalation routes.
• Previous studies indicated potential central neurotoxicity and immune system effects from repeated exposure.
• The risk of systemic toxicity from dermal contact with 2,4 PD required investigation.

Purpose of the Study:

• To evaluate the systemic toxicity of 2,4-Pentanedione following repeated dermal exposure in rabbits.
• To determine the dose-response relationship for cutaneous contact with 2,4 PD.
• To identify the no-observed-adverse-effect level (NOAEL) for systemic toxicity via the dermal route.

Main Methods:

• A short-term repeated dose study using New Zealand white rabbits was conducted.
• Animals received 0.5, 1.0, or 1.5 ml of undiluted 2,4 PD via occlusive dermal contact for 6 hours daily over 9 days.
• Systemic toxicity was assessed through clinical signs, body weight, food consumption, hematology, serum biochemistry, and histopathology.

Main Results:

• Dermal application of 2,4 PD caused dose-dependent skin irritation.
• Mortalities and significant systemic toxicity, including hypoactivity, tremors, convulsions, and prostration, were observed at mid and high dosages.
• Histopathology revealed central neurotoxicity (hemorrhages, neuronal degeneration) and immune effects (lymphoid necrosis, decreased lymphocytes).
• The no-effects dosage for systemic toxicity was determined to be 244 mg/kg/d.

Conclusions:

• Percutaneous absorption of 2,4-Pentanedione can lead to significant systemic toxicity, primarily affecting the central nervous system.
• Dermal exposure to 2,4 PD poses a risk of neurotoxicity and immune system compromise.
• A dosage of 244 mg/kg/d represents the no-effects level for systemic toxicity via dermal exposure.